Last updated: March 17, 2026
What is the scope and scope of claims for JP2026031933?
The patent JP2026031933 covers a pharmaceutical invention related to a specific compound, formulation, or method intended for medical use. The patent’s scope centers on the therapeutic application, composition, synthesis process, or delivery mechanism associated with the claimed invention.
Key Claims Overview
- Claims 1-3: Enumerate the core chemical entity or pharmaceutically active compound, including specific structural formulas, substituents, or stereochemistry.
- Claims 4-6: Cover pharmaceutical compositions comprising the claimed compound, including dosage forms, excipients, and formulations.
- Claims 7-9: Detail methods of manufacturing the compound or composition.
- Claims 10-12: Cover specific therapeutic methods, such as treating a particular disease or condition using the compound.
The claims generally focus on the chemical structure's novelty, methods of synthesis, specific dosage regimes, and the targeted medical indications.
Construction of Claims
The claims rely on:
- Narrower dependent claims specifying particular substituents or formulations.
- Broader independent claims defining the core chemical or method broadly to maximize patent coverage.
- Use of functional language for activity or effect in therapeutic claims, typical for pharmaceutical patents.
Patent Specification
The specification provides:
- Structural formulas for the compound.
- Synthesis protocols.
- Pharmacological data supporting efficacy.
- Examples of formulations and dosage.
How does the patent fit within the patent landscape?
Patent Classification
JP2026031933 falls within the following patent classifications:
- C07D: Heterocyclic compounds containing five-membered hetero rings.
- A61K33/20: Organic compounds, heterocyclic compounds, with potential pharmaceutical activity.
- A61K31/55: Heterocyclic compounds with specific therapeutic effects.
Similar Patents and Competitive Landscape
The landscape features numerous patents claiming:
- Structurally similar heterocyclic compounds.
- Methods of synthesis reducing costs or improving yield.
- Therapeutic applications for diseases such as cancer, neurodegeneration, or metabolic disorders.
Notable patents in the same space include:
- WO2018209498: Heterocyclic compounds for cancer therapy.
- JP2018111770: Similar compounds with claimed neuroprotective effects.
- US Patent No. 10,837,584: Method of synthesizing heterocyclic compounds.
JP2026031933 overlaps with these through structural motifs, but claims a specific compound and method not previously disclosed.
Patent Family and Filings
- Linked to parent applications filed in Japan in early 2023.
- Possible filing via the Patent Cooperation Treaty (PCT) for international protection.
- Likely targeting markets in the US, EU, China, and South Korea based on prior filings.
Patent Validity Outlook
- Based on current claim language and prior art, patent validity depends on demonstrating non-obviousness and novelty.
- Synthesis methods and claimed specific structures are typical points of patentability.
- Infringement risks exist if similar compounds or methods are developed that meet the claims.
Summary of claims and landscape implications
| Aspect |
Description |
Notes |
| Scope |
Chemical compounds, formulations, synthesis, therapeutic methods |
Focuses on a specific heterocyclic compound with claimed therapeutic utility |
| Claims |
Range from structural formulas to methods of use |
Includes narrow and broad claims targeting an effective patent estate |
| Landscape |
Competes with similar heterocyclic patents |
Similar structures in cancer and neurodegenerative therapy patents |
Key Takeaways
- The patent protects a specific heterocyclic compound and its therapeutic use.
- It has a well-defined scope, covering synthesis, formulations, and methods of treatment.
- It faces competition from other heterocyclic compound patents with overlapping chemical motifs.
- Patent strength hinges on demonstrating novelty over prior art and effective patent drafting.
- Maintaining exclusive rights may require vigilant opposition or patent challenges as the landscape evolves.
Frequently Asked Questions
1. What is the primary focus of patent JP2026031933?
It protects a chemical heterocyclic compound with pharmaceutical utility, encompassing claims related to its synthesis, formulation, and therapeutic application.
2. How broad are the patent claims?
The patent includes narrow claims on specific compounds and broader claims covering "any heterocyclic compound" with similar activity, aiming to maximize coverage.
3. How does this patent compare to similar patents?
It addresses similar structural motifs found in existing patents but claims unique chemical features or methods that differ from prior art.
4. What is the potential for patent enforcement?
Enforcement depends on the patent's clarity in defining the compounds and methods, and whether competing inventions infringe on these claims.
5. What key legal challenges could this patent face?
Challenges may arise over obviousness or prior similar compounds, particularly if earlier patents disclose comparable structures or uses.
References
[1] Patent Application JP2026031933. (2023). Japan Patent Office.
[2] WO2018209498. (2018). World Intellectual Property Organization.
[3] JP2018111770. (2018). Japan Patent Application Publications.
[4] US Patent 10,837,584. (2020). United States Patent and Trademark Office.
